<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Catheter Precision, Inc. — News on 6ix</title>
<link>https://6ix.com/company/catheter-precision-inc</link>
<description>Latest news and press releases for Catheter Precision, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/catheter-precision-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d794d624982d98966dc875.webp</url>
<title>Catheter Precision, Inc.</title>
<link>https://6ix.com/company/catheter-precision-inc</link>
</image>
<item>
<title>Catheter Precision Secures U.S. Patent Allowance on Foundational Surgical Technology, Establishing Powerful IP and Accelerating Scalable Growth Strategy</title>
<link>https://6ix.com/company/catheter-precision-inc/news/catheter-precision-secures-us-patent-allowance-on-foundational-surgical-technology-establishing-powerful-ip-and-accelerating-scalable-growth-strategy</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/catheter-precision-secures-us-patent-allowance-on-foundational-surgical-technology-establishing-powerful-ip-and-accelerating-scalable-growth-strategy</guid>
<pubDate>Tue, 21 Apr 2026 12:00:00 GMT</pubDate>
<description>USPTO Validates Catheter Precision’s LockeT Technology with Key Patent Allowance, Reinforcing Competitive Dominance, Long-Term Value Creation and Strengthening Barriers to EntryFORT MILL, S.C., April 21, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for key claims covering its proprietary surgical vessel closing pressure device, marking a significant milestone in</description>
</item>
<item>
<title>VTAK Definitive Agreement to Acquire 100% of Fly Flyte Inc. Obtains Shareholder Approval</title>
<link>https://6ix.com/company/catheter-precision-inc/news/vtak-definitive-agreement-to-acquire-100percent-of-fly-flyte-inc-obtains-shareholder-approval</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/vtak-definitive-agreement-to-acquire-100percent-of-fly-flyte-inc-obtains-shareholder-approval</guid>
<pubDate>Thu, 16 Apr 2026 12:00:00 GMT</pubDate>
<description>Transaction Delivers Fully Consolidated, Revenue-Generating, Aviation Business with Accelerating Growth Positions VTAK for Scalable Expansion in Regional Air Mobility Ahead of eVTOL Commercialization FORT MILL, S.C., April 16, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) today announced it received shareholder approval on April 15th of the definitive agreement to acquire Fly Flyte, Inc. (“Flyte”) executed on March 9. The March 9th transaction establishes Flyte as a who</description>
</item>
<item>
<title>Catheter Precision Announces Accepted Publication in Leading European Medical Journal</title>
<link>https://6ix.com/company/catheter-precision-inc/news/catheter-precision-announces-accepted-publication-in-leading-european-medical-journal</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/catheter-precision-announces-accepted-publication-in-leading-european-medical-journal</guid>
<pubDate>Mon, 13 Apr 2026 12:00:00 GMT</pubDate>
<description>Clinical Evidence Further Demonstrates Efficacy and Accuracy of VIVO for Ventricular ProceduresFORT MILL, S.C., April 13, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that the results of a recently concluded VIVO study have been accepted in EP Europace, the leading European electrophysiology journal. The EP Europace journal provides an avenue of communication for top-quality European and international original, scientific work</description>
</item>
<item>
<title>Catheter Precision to Attend the Annual European Heart Rhythm Association Conference</title>
<link>https://6ix.com/company/catheter-precision-inc/news/catheter-precision-to-attend-the-annual-european-heart-rhythm-association-conference</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/catheter-precision-to-attend-the-annual-european-heart-rhythm-association-conference</guid>
<pubDate>Wed, 08 Apr 2026 12:00:00 GMT</pubDate>
<description>FORT MILL, S.C., April 08, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that it will be attending the annual European Heart Rhythm Association (EHRA) conference in Paris, France from April 12-14, 2026. EHRA is one of several conferences supported by the European Society of Cardiology whose mission is to reduce the number of people with cardiovascular diseases by connecting cardiovascular health professionals around the world to</description>
</item>
<item>
<title>New LockeT Data Accepted in Leading Electrophysiology Journal</title>
<link>https://6ix.com/company/catheter-precision-inc/news/new-locket-data-accepted-in-leading-electrophysiology-journal</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/new-locket-data-accepted-in-leading-electrophysiology-journal</guid>
<pubDate>Mon, 06 Apr 2026 12:00:00 GMT</pubDate>
<description>FORT MILL, S.C., April 06, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that the manuscript titled “Safety and Efficacy of LockeT Suture Retention Device for Large-Bore Venous Access Closure” has been accepted by the Journal of Interventional Cardiac Electrophysiology (JICE), a leading medical journal in the field of electrophysiology. This publication confirmed the safety and efficacy of LockeT for large-bore venous closure in</description>
</item>
<item>
<title>Catheter Precision Engages Strategic Advisor</title>
<link>https://6ix.com/company/catheter-precision-inc/news/catheter-precision-engages-strategic-advisor-80</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/catheter-precision-engages-strategic-advisor-80</guid>
<pubDate>Thu, 02 Apr 2026 12:00:00 GMT</pubDate>
<description>Goal to unlock value in cardiac electrophysiology assets Strategic process to include outreach to leading global medical device companiesFORT MILL, S.C., April 02, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that it has engaged a strategic advisor to formally market for sale its cardiac electrophysiology business. This strategic initiative is designed to create shareholder value by monetizing the Company’s legacy medical devic</description>
</item>
<item>
<title>Catheter Precision Reports 2025 Results and Updates on Strategic Expansion</title>
<link>https://6ix.com/company/catheter-precision-inc/news/catheter-precision-reports-2025-results-and-updates-on-strategic-expansion</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/catheter-precision-reports-2025-results-and-updates-on-strategic-expansion</guid>
<pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate>
<description>Clinical, Commercial and Regulatory Milestones Achieved in 2025 Establish a Strong Foundation in Life Sciences as Revenue Increases 95% Year Over Year Acquisition of Flyte and Strengthened Capital Position Unlock Multi-Segment Growth Strategy with Multiple Near-Term Catalysts FORT MILL, S.C., March 31, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”), a U.S.-based innovative medical device company focused on electrophysiology products, today annou</description>
</item>
<item>
<title>Flyte Hops: Vision Jet Platform Seeks to Redefine Private Aviation</title>
<link>https://6ix.com/company/catheter-precision-inc/news/flyte-hops-vision-jet-platform-seeks-to-redefine-private-aviation</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/flyte-hops-vision-jet-platform-seeks-to-redefine-private-aviation</guid>
<pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
<description>Hops Scalable Vision Jet Fleet Expansion Unlocking High-Frequency Short-Haul Regional Travel Flyte’s Vision Jet-Powered Hops Platform Aims to Establish a New Standard in Regional Travel with Industry-Leading Safety, Speed, Efficiency and Affordability FORT MILL, S.C., March 25, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) and its wholly-owned subsidiary Fly Flyte, Inc. (“Flyte”), today announced the expansion of its Vision Jet-powered Hops platform, a scalable short-ha</description>
</item>
<item>
<title>Flyte Launches Florida Hops to Service Accelerating Demand</title>
<link>https://6ix.com/company/catheter-precision-inc/news/flyte-launches-florida-hops-to-service-accelerating-demand</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/flyte-launches-florida-hops-to-service-accelerating-demand</guid>
<pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
<description>Fleet Expansion Underway With Five Vision Jets Expected to Be Operating by Memorial Day Regional Aviation Platform Now Connects Entire East Coast Following Successful Soft Launch in Florida FORT MILL, S.C., March 16, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) today announced the official launch of Flyte Hops Florida, expanding Flyte’s regional aviation network from its original New York-based service to now providing multiple aircraft along the entire East Coast from</description>
</item>
<item>
<title>Catheter Precision, Inc. Secures up to $88 Million in Strategic Institutional Financing Commitments to Fund Accelerated Growth</title>
<link>https://6ix.com/company/catheter-precision-inc/news/catheter-precision-inc-secures-up-to-dollar88-million-in-strategic-institutional-financing-commitments-to-fund-accelerated-growth</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/catheter-precision-inc-secures-up-to-dollar88-million-in-strategic-institutional-financing-commitments-to-fund-accelerated-growth</guid>
<pubDate>Wed, 11 Mar 2026 12:00:00 GMT</pubDate>
<description>Fully Funded Growth Strategy Supports Aircraft Fleet Expansion Providing Capacity to Service Current Demand in New RegionsFORT MILL, S.C., March 11, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) today announced transformational balance sheet improvements through new institutional capital commitments supporting the Company’s next phase of growth. Fully Funded Growth StrategyFly Flyte, Inc. (“Flyte”), a newly acquired subsidiary of VTAK, is now positioned to execute its e</description>
</item>
<item>
<title>VTAK Announces Definitive Merger Agreement to Acquire 100% of Fly Flyte Inc.</title>
<link>https://6ix.com/company/catheter-precision-inc/news/vtak-announces-definitive-merger-agreement-to-acquire-100percent-of-fly-flyte-inc</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/vtak-announces-definitive-merger-agreement-to-acquire-100percent-of-fly-flyte-inc</guid>
<pubDate>Tue, 10 Mar 2026 12:00:00 GMT</pubDate>
<description>Transaction Delivers Wholly Owned, Scalable Asset-Backed, Aviation Platform with Accelerating Revenue and Consolidated Control Positions VTAK at the Center of High-Growth Regional Air Mobility Ahead of Industry-Wide eVTOL CommercializationFORT MILL, S.C., March 10, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) today announced that it has completed the acquisition of the remaining 80.02% equity interest in Fly Flyte, Inc. (“Flyte”) from Creatd, Inc. (OTCQB: CRTDD), resul</description>
</item>
<item>
<title>Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at ISLAA 2026</title>
<link>https://6ix.com/company/catheter-precision-inc/news/catheter-precisions-locket-suture-retention-device-to-be-featured-in-live-cases-at-islaa-2026-32</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/catheter-precisions-locket-suture-retention-device-to-be-featured-in-live-cases-at-islaa-2026-32</guid>
<pubDate>Fri, 06 Mar 2026 13:00:00 GMT</pubDate>
<description>FORT MILL, S.C., March 06, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a pioneer in medical technology for the cardiac electrophysiology market, today announced that its LockeT suture retention device will be highlighted during live procedural cases at the International Symposium of Left Atrial Appendage 2026 conference. The event, co-hosted by the Academy for Continued Healthcare Learning (ACHL) and ISLAA Foundation, will take place from March 5-6, 2026, at the Bilt</description>
</item>
<item>
<title>Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth</title>
<link>https://6ix.com/company/catheter-precision-inc/news/catheter-precision-announces-strategic-sale-of-non-core-assets-to-strengthen-balance-sheet-and-accelerate-electrophysiology-growth</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/catheter-precision-announces-strategic-sale-of-non-core-assets-to-strengthen-balance-sheet-and-accelerate-electrophysiology-growth</guid>
<pubDate>Thu, 19 Feb 2026 13:15:00 GMT</pubDate>
<description>Upfront Cash, Equity Participation and Tiered Royalty Structure Providing Long-Term Revenue UpsideFORT MILL, S.C., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a leader in advanced electrophysiology solutions, today announced it has entered into a definitive agreement to divest its atherectomy catheter technologies, including associated FDA approvals and patents, to a strategic acquirer. Following a comprehensive portfolio review, the Company determined that</description>
</item>
<item>
<title>VTAK Acquires 20% Interest in Creatd’s Subsidiary Fly Flyte, Inc.</title>
<link>https://6ix.com/company/catheter-precision-inc/news/vtak-acquires-20percent-interest-in-creatds-subsidiary-fly-flyte-inc-1</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/vtak-acquires-20percent-interest-in-creatds-subsidiary-fly-flyte-inc-1</guid>
<pubDate>Tue, 17 Feb 2026 19:17:00 GMT</pubDate>
<description>Strategic Partnership: Creatd expanded Fly Flyte’s investor network by adding NYSE-listed VTAK as an investor in its subsidiary.Portfolio Expansion: Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.Innovation in Aviation: Fly Flyte, Inc. is transforming regional aviation through accessibility, convenience, and technology-driven operations. NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTD) announced that Catheter Precision, Inc</description>
</item>
<item>
<title>VTAK Acquires 19.98% Strategic Stake in AI-Enabled Aviation Company Fly Flyte, Inc.</title>
<link>https://6ix.com/company/catheter-precision-inc/news/vtak-acquires-1998percent-strategic-stake-in-ai-enabled-aviation-company-fly-flyte-inc</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/vtak-acquires-1998percent-strategic-stake-in-ai-enabled-aviation-company-fly-flyte-inc</guid>
<pubDate>Tue, 17 Feb 2026 12:45:00 GMT</pubDate>
<description>Immediate Exposure to Revenue-Generating, Asset-Backed Regional Air Mobility Business Positioned Ahead of Anticipated Future Industry-wide eVTOL Commercialization Strategic Investment Expands Capital Allocation into High-Growth Infrastructure with Scalable Fleet Expansion and Long-Term Equity Upside Fort Mill, S.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) today announced a strategic minority investment in Fly Flyte, Inc. (“Flyte”), an FAA-certified region</description>
</item>
<item>
<title>Catheter Precision, Inc. Secures up to $36.5 Million in Strategic Institutional Financing to Accelerate Growth</title>
<link>https://6ix.com/company/catheter-precision-inc/news/catheter-precision-inc-secures-up-to-dollar365-million-in-strategic-institutional-financing-to-accelerate-growth</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/catheter-precision-inc-secures-up-to-dollar365-million-in-strategic-institutional-financing-to-accelerate-growth</guid>
<pubDate>Thu, 12 Feb 2026 12:15:00 GMT</pubDate>
<description>VTAK has Agreed to Terminate its At-The-Market (“ATM”) Equity Offering Program Company Strengthens Balance Sheet and Aligns Institutional Capital for Long-Term Value Creation FORT MILL, S.C., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“Catheter Precision” or the “Company”), a leader in advanced electrophysiology solutions, today announced that it has agreed to the termination of its at-the-market (“ATM”) equity offering program and has completed a strategic</description>
</item>
<item>
<title>Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at Scripps’ Structural Heart Intervention and Imaging 2026 Conference</title>
<link>https://6ix.com/company/catheter-precision-inc/news/catheter-precisions-locket-suture-retention-device-to-be-featured-in-live-cases-at-scripps-structural-heart-intervention-and-imaging-2026-conference</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/catheter-precisions-locket-suture-retention-device-to-be-featured-in-live-cases-at-scripps-structural-heart-intervention-and-imaging-2026-conference</guid>
<pubDate>Thu, 05 Feb 2026 13:00:00 GMT</pubDate>
<description>FORT MILL, S.C., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a pioneer in medical technology for the cardiac electrophysiology market, today announced that its LockeT suture retention device will be highlighted during live procedural cases at the Structural Heart Intervention and Imaging: A Practical Approach 2026 conference. The event, hosted by Scripps Health, will take place from February 11–13, 2026, at the Hyatt Regency La Jolla at Aventine in San Diego</description>
</item>
<item>
<title>Catheter Precision Announces Accelerated Momentum for LockeT Device with New Hospital Approvals and Strong Q1 Adoption Outlook</title>
<link>https://6ix.com/company/catheter-precision-inc/news/catheter-precision-announces-accelerated-momentum-for-locket-device-with-new-hospital-approvals-and-strong-q1-adoption-outlook</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/catheter-precision-announces-accelerated-momentum-for-locket-device-with-new-hospital-approvals-and-strong-q1-adoption-outlook</guid>
<pubDate>Wed, 04 Feb 2026 13:00:00 GMT</pubDate>
<description>FORT MILL, S.C., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a medical device company specializing in advanced electrophysiology solutions, today announced a surge in hospital evaluations and approvals for its LockeT suture retention device. As the company enters the first quarter of 2026, it reports significant progress in domestic and international product adoption, driven by successful clinical outcomes and the device's ability to streamline hospital work</description>
</item>
<item>
<title>Catheter Precision Receives First Purchase Order for LockeT in Germany</title>
<link>https://6ix.com/company/catheter-precision-inc/news/catheter-precision-receives-first-purchase-order-for-locket-in-germany</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/catheter-precision-receives-first-purchase-order-for-locket-in-germany</guid>
<pubDate>Thu, 22 Jan 2026 13:00:00 GMT</pubDate>
<description>FORT MILL, S.C., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced receipt of a LockeT purchase order from Universitätsklinikum Frankfurt (Frankfurt University Hospital). This purchase order marks the official entry of LockeT into Germany. The purchase order includes the LockeT suture retention device, a state-of-the-a</description>
</item>
<item>
<title>Catheter Precision Received new VIVO Purchase Order from Leading Hospital in Slovenia</title>
<link>https://6ix.com/company/catheter-precision-inc/news/catheter-precision-received-new-vivo-purchase-order-from-leading-hospital-in-slovenia</link>
<guid isPermaLink="true">https://6ix.com/company/catheter-precision-inc/news/catheter-precision-received-new-vivo-purchase-order-from-leading-hospital-in-slovenia</guid>
<pubDate>Tue, 20 Jan 2026 13:00:00 GMT</pubDate>
<description>Expands Global Footprint to 15 CountriesFORT MILL, S.C., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced receipt of a VIVO purchase order from University Clinical Center Ljubljana, a leading hospital in Slovenia. This expands Catheter Precision’s global sales footprint to 15 countries. The University Clinical Center</description>
</item>
</channel>
</rss>